FDG-PET Imaging in Cervical Cancer.
Journal
Seminars in nuclear medicine
ISSN: 1558-4623
Titre abrégé: Semin Nucl Med
Pays: United States
ID NLM: 1264464
Informations de publication
Date de publication:
11 2019
11 2019
Historique:
entrez:
22
10
2019
pubmed:
22
10
2019
medline:
11
4
2020
Statut:
ppublish
Résumé
FDG-PET/CT has an established role in the initial staging of locally advanced cervical cancers, particularly in evaluation of nodal disease and distant metastases. It is common practice to perform FDG-PET/CT 3 months postcompletion of chemoradiotherapy as it can predict outcome and be used to tailor management, including adjuvant therapy and follow-up. It is also routinely used prior to pelvic exenterative surgery to ensure there is no disease outside the pelvis. There is growing evidence that FDG-PET-derived parameters are prognostic and could potentially be used to tailor therapy. This review outlines the use of FDG-PET/CT imaging in cervical cancer.
Identifiants
pubmed: 31630730
pii: S0001-2998(19)30056-X
doi: 10.1053/j.semnuclmed.2019.06.007
pii:
doi:
Substances chimiques
Fluorodeoxyglucose F18
0Z5B2CJX4D
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
461-470Subventions
Organisme : Cancer Research UK
ID : 12783
Pays : United Kingdom
Informations de copyright
Crown Copyright © 2019. Published by Elsevier Inc. All rights reserved.